R.M. Riggin

3.7k total citations
47 papers, 2.9k citations indexed

About

R.M. Riggin is a scholar working on Molecular Biology, Spectroscopy and Biomedical Engineering. According to data from OpenAlex, R.M. Riggin has authored 47 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Spectroscopy and 10 papers in Biomedical Engineering. Recurrent topics in R.M. Riggin's work include Analytical Chemistry and Chromatography (14 papers), Advanced Chemical Sensor Technologies (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). R.M. Riggin is often cited by papers focused on Analytical Chemistry and Chromatography (14 papers), Advanced Chemical Sensor Technologies (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). R.M. Riggin collaborates with scholars based in United States. R.M. Riggin's co-authors include Peter T. Kissinger, W.T. Winberry, David J. Miner, Gerald W. Becker, Roosevelt Alcorn, Michael J. Pikal, Eugene C. Rickard, Lihua Huang, John R. Rice and Jirong Lu and has published in prestigious journals such as Nature Biotechnology, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

R.M. Riggin

46 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.M. Riggin United States 26 852 636 568 479 335 47 2.9k
Kenichiro Nakashima Japan 36 967 1.1× 1.4k 2.1× 794 1.4× 710 1.5× 476 1.4× 277 4.9k
Naotaka Kuroda Japan 31 985 1.2× 914 1.4× 743 1.3× 770 1.6× 198 0.6× 201 3.7k
Michael G. Bartlett United States 39 2.0k 2.4× 1.2k 2.0× 656 1.2× 238 0.5× 472 1.4× 206 4.8k
Nuran Erçal United States 45 1.5k 1.8× 305 0.5× 225 0.4× 1.4k 2.9× 223 0.7× 121 5.8k
Hua‐Shan Zhang China 35 1.1k 1.3× 975 1.5× 1.2k 2.1× 509 1.1× 154 0.5× 176 4.8k
Paola Manini Italy 39 1.1k 1.3× 732 1.2× 680 1.2× 867 1.8× 229 0.7× 187 5.0k
Reinhard Oertel Germany 33 596 0.7× 417 0.7× 339 0.6× 196 0.4× 614 1.8× 107 3.5k
Federica Bianchi Italy 38 907 1.1× 887 1.4× 970 1.7× 319 0.7× 207 0.6× 163 4.5k
John Savory United States 29 549 0.6× 205 0.3× 129 0.2× 468 1.0× 133 0.4× 96 2.8k
Bong Chul Chung South Korea 38 2.1k 2.4× 951 1.5× 303 0.5× 261 0.5× 236 0.7× 201 4.4k

Countries citing papers authored by R.M. Riggin

Since Specialization
Citations

This map shows the geographic impact of R.M. Riggin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M. Riggin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M. Riggin more than expected).

Fields of papers citing papers by R.M. Riggin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.M. Riggin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M. Riggin. The network helps show where R.M. Riggin may publish in the future.

Co-authorship network of co-authors of R.M. Riggin

This figure shows the co-authorship network connecting the top 25 collaborators of R.M. Riggin. A scholar is included among the top collaborators of R.M. Riggin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.M. Riggin. R.M. Riggin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Lihua, Jirong Lu, Victor J. Wroblewski, John M. Beals, & R.M. Riggin. (2005). In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS. Analytical Chemistry. 77(5). 1432–1439. 211 indexed citations
3.
Riggin, R.M., et al.. (1997). Development of an optimized peptide map for recombinant activated human protein C by means of an experimental design strategy. Analytica Chimica Acta. 352(1-3). 221–230. 2 indexed citations
4.
Felder, Christian C., Eileen M. Briley, Miklós Palkovits, et al.. (1996). Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Letters. 393(2-3). 231–235. 276 indexed citations
5.
Riggin, R.M., et al.. (1996). [4] Protein liquid chromatographic analysis in biotechnology. Methods in enzymology on CD-ROM/Methods in enzymology. 271. 86–113. 6 indexed citations
6.
Riggin, R.M.. (1996). High performance liquid chromatography: Principles and methods in biotechnology. Journal of Chromatography A. 746(2). 301–302. 11 indexed citations
7.
Becker, Gerald W., et al.. (1995). Protein mass spectrometry: applications to analytical biotechnology. Journal of Chromatography A. 705(1). 21–45. 84 indexed citations
8.
Becker, Gerald W., James R. Miller, S Kovacevic, et al.. (1994). Characterization by Electrospray Mass Spectrometry of Human Ca2+–sensitive Cytosolic Phospholipase A2 Produced in Baculovirus–infected Insect Cells. Nature Biotechnology. 12(1). 69–74. 23 indexed citations
9.
10.
Allen, Norris E., J N Hobbs, J. M. Richardson, & R.M. Riggin. (1992). Biosynthesis of modified peptidoglycan precursors by vancomycin-resistantEnterococcus faecium. FEMS Microbiology Letters. 98(1-3). 109–115. 22 indexed citations
11.
Pikal, Michael J., et al.. (1991). The Effects of Formulation Variables on the Stability of Freeze-Dried Human Growth Hormone. Pharmaceutical Research. 8(4). 427–436. 215 indexed citations
12.
Riggin, R.M., et al.. (1989). Capillary zone electrophoresis of peptide fragments from trypsin digestion of biosynthetic human growth hormone. Journal of Chromatography A. 480. 393–401. 57 indexed citations
13.
Farid, Nazar, et al.. (1989). Liquid chromatographic control of the identity, purity and “potency” of biomolecules used as drugs. Journal of Pharmaceutical and Biomedical Analysis. 7(2). 185–188. 25 indexed citations
14.
Riggin, R.M., et al.. (1988). High-performance size-exclusion chromatographic determination of the potency of biosynthetic human growth hormone products. Journal of Chromatography A. 435(2). 307–318. 26 indexed citations
15.
Riggin, R.M., et al.. (1987). A reversed-phase high-performance liquid chromatographic method for characterization of biosynthetic human growth hormone. Analytical Biochemistry. 167(1). 199–209. 51 indexed citations
16.
Riggin, R.M., et al.. (1983). High Performance Liquid Chromatographic Determination of Phenylenediamines in Aqueous Environmental Samples. Journal of Liquid Chromatography. 6(10). 1897–1905. 7 indexed citations
17.
Riggin, R.M., et al.. (1979). Determination of benzidine, dichlorobenzidine, and diphenylhydrazine in aqueous media by high performance liquid chromatography. Analytical Chemistry. 51(2). 210–214. 59 indexed citations
18.
Riggin, R.M.. (1976). RAPID DETERMINATION OF CATECHOLAMINES AND RELATED PHENOLIC COMPOUNDS IN BIOLOGICAL MEDIA.. Purdue e-Pubs (Purdue University System). 1 indexed citations
19.
Riggin, R.M., Allen Schmidt, & Peter T. Kissinger. (1975). Determination of Acetaminophen in Pharmaceutical Preparations and Body Fluids by High-Performance Liquid Chromatography with Electrochemical Detection. Journal of Pharmaceutical Sciences. 64(4). 680–683. 69 indexed citations
20.
Kissinger, Peter T., et al.. (1974). Electrochemical Detection of Selected Organic Components in the Eluate from High-Performance Liquid-Chromatography. Clinical Chemistry. 20(8). 992–997. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026